Tình trạng methyl hóa của gen ức chế khối u p16 INK4A ở bệnh nhân ung thư vú không di truyền tại Iran

Baur AS, Shaw P, Burri N et al (1999) Frequent silencing of p15INK4b(MTS2) and p16INK4a(MTS1) in B-cell and T-cell lymphomas. Blood 94:1773–1781 Baylin S, Herman G (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16:168–174. doi:10.1016/S0168-9525(99)01971-X Bender C, Pao M, Jones A (1998) Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 58(1):95–101 Bo Z, Ke L, Jianying C, Guobin W et al (2007) Effects of 5-Aza-CdR on cell proliferation of breast cancer cell line MDA-MB-435S and expression of maspin gene. J Huazhong Univ Sci 27(5):543–546. doi:10.1007/s11596-007-0517-z Brenner A, Wang A, Olopade O et al (1996) Preferential loss of expression of 16INK4a rather than p14 in breast cancer. Clin Cancer Res 2:993–1998 Calvano J, Rush E, Tan L et al (1997) Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens. Ann Surg Oncol 4:416–420. doi:10.1007/BF02305555 David L, Yegnasubramanian S, Kumar A et al (2004) MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-aza-cytidine. Cancer Biol Ther 3:540–548 Dominguez G, Silva J, Garcia J et al (2003) Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors. Mutat Res 530:9–17. doi:10.1016/S0027-5107(03)00133-7 Egger G, Liang G, Aparicio A et al (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457–463. doi:10.1038/nature02625 Foster S, Wong D, Barrett M et al (1998) Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 18:1793–1801 Gonzalez-Zulueta M, Bender CM, Yang AS et al (2000) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55:4531–4535 Herman J, Merlo A, Mao L et al (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525–4530 Herman J, Graff J, Myohanen S et al (1996) Methylation specific PCR: a novel PCR assay for methylation status of CpG islands. Acad Sci 93:9821–9826. doi:10.1073/pnas.93.18.9821 Holst C, Nuovo G, Esteller M et al (2003) Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 63:1596–1601 Jones PL, Veenstra GJ, Wade PA et al (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187–191. doi:10.1038/561 Kannan K, Sharpless N, Xu J et al (2003) Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc Natl Acad Sci USA 100(3):1221–1225. doi:10.1073/pnas.0336397100 Lallemand D, Spyrou G, Yaniv M et al (1997) Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts. Oncogene 14:819–830. doi:10.1038/sj.onc.1200901 Lars AL, Cathrine J, Paal SK (2007) Single-strand conformation polymorphism analysis using capillary array electrophoresis for large scale mutation detection. Nat Protoc 2:1458–1466 Li S, Rong M, Iacopetta B et al (2006) DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett 237:272–280. doi:10.1016/j.canlet.2005.06.011 Magdinier F, Wolffe AP et al (2001) Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc Natl Acad Sci USA 98:4990–4995. doi:10.1073/pnas.101617298 Malumbres M, Castro IPD, Hernández MI et al (2000) Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15INK4b. Mol Cell Biol 20:2915–2925. doi:10.1128/MCB.20.8.2915-2925.2000 Mao L, Merlo A, Bedi G et al (1995) A novel p16INK4A transcript. Cancer Res 55:2995–2997 Munot K, Bell K, Lane S et al (2006) Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Hum Pathol 37:989–999. doi:10.1016/j.humpath.2006.04.013 Myohanen SK, Baylin SB, Herman JG et al (1998) Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 58:591–593 Nielsen H, Roosa G, Emdinc S et al (2001) Methylation of the p16Ink4a tumor suppressor gene 5′-CpG island in breast cancer. Cancer Lett 163(1):59–69. doi:10.1016/S0304-3835(00)00674-1 Parrella P, Luana Poeta M, Gallo P et al (2004) Adolfo Apicella, nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res 10:5349–5354. doi:10.1158/1078-0432.CCR-04-0555 Quesnel B, Fenaux P, Philippe N et al (1995) Analysis of p16 gene deletion and point mutation in breast carcinoma. Br J Cancer 72:351–353 Reynolds P, Sigaroudinia M, Zardo G et al (2006) Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. Bio Chem 281(34):24790–24802 Roccoa J, Sidransky D (2001) p16 (MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264:42–55. doi:10.1006/excr.2000.5149 Romanov S, Kozakiewicz K, Charles R et al (2001) Normal human mammary epithelial cells spontaneously emerge from senescence and acquire genomic instability. Nature 409:633–637. doi:10.1038/35054579 Sambrook J, Fritsh E, Maniatis T et al (2001) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor Segura-Pacheco B, Trejo-Becerril C, Perez-Cardenas E et al (2003) Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. Clin Cancer Res 9:1596–1603 Serrano M, Hannon G, Beach D et al (1999) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704–707. doi:10.1038/366704a0 Villar-Garea A, Fraga M, Espada J et al (2003) Procaine is a DNA demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res 63:4984–4989 Voorhoeve M, Agami R (2003) The tumor-suppressive functions of the human INK4A locus. Cancer Cell 4:311–319. doi:10.1016/S1535-6108(03)00223-X Zee K, Calvano J, Bisogna M et al (1998) Hypomethylation and increased gene expression of p16Ink4a in primary and metastatic breast carcinoma as compared to normal breast tissue. Oncogene 16:2723–2727. doi:10.1038/sj.onc.1201794